Conference to discuss innovation in Harley Street area

On 4 October,2022 | In News

World-leading institutions will discuss the future of life science innovation at The Harley Street Medical Area Healthcare Conference on Wednesday 19 October.

This one-day conference, entitled London: A Global Hub for Life Sciences, at The Royal Society of Medicine will be hosted by The Howard de Walden Estate – landlord and steward of 92 acres of Marylebone including the Harley Street Medical Area.

Speakers from some of London’s world-leading institutions will talk about global trends in the life sciences sector and how the city is driving and responding to those trends.

Prof Lord Kakkar

The event, chaired by Prof Lord Kakkar, professor of surgery at King’s College Hospital, will explore why London’s infrastructure makes it particularly well suited to foster collaboration and innovation – and how businesses can tap into the opportunities and support network available.

Howard de Walden’s chief executive Mark Kildea said: ‘There are a number of reasons why we are looking at Life Sciences across the Estate. The proximity of Marylebone to King’s Cross, organisations like the Francis Crick Institute and the major London universities means we all well connected. 

‘We’ve got extensive experience in retrofitting heritage buildings so they are suitable for specialised medical use and the range of properties we own means we can support organisations from the incubator stage through to scale-up.

‘However, our main ambition is to facilitate collaboration. The halthcare sector is at the core of our estate – we’re home to a wide range of hospitals and clinics. Healthcare and life sciences are inseparable, and we want to enable life sciences organisations to tap into the healthcare opportunities within our estate, connecting research, private capital and hospitals.’

Conference speakers:

A Vision for the 21st Century 

Sir Robert Lechler, King’s Health Partners Academic Health Sciences Centre, senior vice president/Provost (Health) and executive director 

The Journey of Life Sciences 

Dr Annalisa Jenkins, London School of Hygiene and Tropical Medicine, Cyte Ltd Global Network for Clinic Research, director

Martin Murphy, chief executive, Syncona Investment Management Ltd

Prof Tony Young, Anglia Ruskin University, director of medical innovation, surgeon and National Clinical Lead for Innovation at NHS London

A National Viewpoint 

Simon Denegri, executive director of the Academy of Medical Sciences 

Sir Rory Collins, University of Oxford, professor of medicine and epidemiology at the Clinical Trust Service

George Freeman MP, former Minister for Science, Research and Innovation

Making it Happen in London

Mark Kildea, The Howard de Walden Estate chief executive

Dr Brian Donley, Cleveland Clinic chief executive

Anne Rafferty, former Lord Justice of Appeal, former vice-chairman of the Judicial Appointments Commission and former chairman of the Judicial College

Organisers said delegates will have the chance to hear – and contribute to – a wide-ranging programme of debates throughout the day.